Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Mitochondrial nanotargeting in malignancies (Review)

  • Authors:
    • Anamaria Magdalena Tomşa
    • Andrei Picoş
    • Alina Monica Picoş
    • Andreea Liana Răchişan
  • View Affiliations / Copyright

    Affiliations: Department of Mother and Child, Second Pediatric Clinic, ‘Iuliu Haţieganu’ University of Medicine and Pharmacy, 400012 Cluj‑Napoca, Romania, Department of Oral Rehabilitation, ‘Iuliu Haţieganu’ University of Medicine and Pharmacy, 400012 Cluj‑Napoca, Romania, Department of Prosthetics and Dental Materials, ‘Iuliu Haţieganu’ University of Medicine and Pharmacy, 400012 Cluj‑Napoca, Romania
  • Pages: 3444-3451
    |
    Published online on: July 17, 2020
       https://doi.org/10.3892/etm.2020.9023
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Malignancies represent a burden for the health system worldwide. Treating them represents a challenge through the prism of the cancer cell behaviour and the serious systemic side effects that usually occur. Both traditional (chemotherapy, radiotherapy and surgery) and associated therapies (immunotherapy and hormone therapy) have reached a plateau. The new trend for the management of malignancies includes nanoparticles (NPs) which are studied for both their diagnostic and therapeutical use. NPs can be designed in various ways, many of them targeting mitochondria causing cellular apoptosis. This review summarizes the main characteristics of NPs that are studied in different cancers to highlight their mechanism of action. Since mitochondria play a key role in the cellular homeostasis, they represent the main target for the experimental current studies. While there are NPs approved by the FDA for clinical use, most of them are still under extended research and still need to prove their efficacy and biocompatibility, preferable with minimal systemic side effects.
View Figures
View References

1 

Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, Schuebbe G, Renz BW, D'Haese JG, Schloesser H, et al: Advances in cancer immunotherapy 2019 - latest trends. J Exp Clin Cancer Res. 38(268)2019.PubMed/NCBI View Article : Google Scholar

2 

Singh M, Harris-Birtill DCC, Markar SR, Hanna GB and Elson DS: Application of gold nanoparticles for gastrointestinal cancer theranostics: A systematic review. Nanomedicine (Lond). 11:2083–2098. 2015.PubMed/NCBI View Article : Google Scholar

3 

Nayak D, Minz AP, Ashe S, Rauta PR, Kumari M, Chopra P and Nayak B: Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines. J Colloid Interface Sci. 470:142–152. 2016.PubMed/NCBI View Article : Google Scholar

4 

Hockl PF, Wolosiuk A, Pérez-Sáez JM, Bordoni AV, Croci DO, Toum-Terrones Y, Soler-Illia GJAA and Rabinovich GA: Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet. Pharmacol Res. 109:45–54. 2016.PubMed/NCBI View Article : Google Scholar

5 

Ancuceanu R, Dinu M, Neaga I, Laszlo FG and Boda D: Development of QSAR machine learning-based models to forecast the effect of substances on malignant melanoma cells. Oncol Lett. 17:4188–4196. 2019.PubMed/NCBI View Article : Google Scholar

6 

Solomon I, Voiculescu VM, Caruntu C, Lupu M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C, et al: Neuroendocrine factors and head and neck squamous cell carcinoma: An affair to remember. Dis Markers. 2018(9787831)2018.PubMed/NCBI View Article : Google Scholar

7 

Jooste V, Remontet L, Colonna M, Belot A, Launoy G, Binder F, Faivre J and Bouvier AM: Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010. Eur J Cancer Prev. 20:375–380. 2011.PubMed/NCBI View Article : Google Scholar

8 

Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE, Voiculescu V, et al: Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int J Oncol. 52:637–655. 2018.PubMed/NCBI View Article : Google Scholar

9 

Pei X, Song F and Wang Z: Emerging incidence trends and application of curative treatments of pancreatic cancer in the USA. Medicine (Baltimore). 98(e17175)2019.PubMed/NCBI View Article : Google Scholar

10 

Zeng S, Pöttler M, Lan B, Grützmann R, Pilarsky C and Yang H: Chemoresistance in pancreatic cancer. Int J Mol Sci. 20(4504)2019.PubMed/NCBI View Article : Google Scholar

11 

Pellino A, Riello E, Nappo F, Brignola S, Murgioni S, Djaballah SA, Lonardi S, Zagonel V, Rugge M, Loupakis F, et al: Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives. World J Gastroenterol. 25:5773–5788. 2019.PubMed/NCBI View Article : Google Scholar

12 

Hall WA and Goodman KA: Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. Radiat Oncol. 14(114)2019.PubMed/NCBI View Article : Google Scholar

13 

Dekker E, Tanis PJ, Vleugels JLA, Kasi PM and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.PubMed/NCBI View Article : Google Scholar

14 

Blundon MA and Dasgupta S: Metabolic dysregulation controls endocrine therapy-resistant cancer recurrence and metastasis. Endocrinology. 160:1811–1820. 2019.PubMed/NCBI View Article : Google Scholar

15 

Wang S, Cowley LA and Liu XS: Sex Differences in cancer immunotherapy efficacy, biomarkers, and therapeutic strategy. Molecules. 24(3214)2019.PubMed/NCBI View Article : Google Scholar

16 

Li Y, Ayala-Orozco C, Rauta PR and Krishnan S: The application of nanotechnology in enhancing immunotherapy for cancer treatment: Current effects and perspective. Nanoscale. 11:17157–17178. 2019.PubMed/NCBI View Article : Google Scholar

17 

Lin W: Introduction: Nanoparticles in medicine. Chem Rev. 115:10407–10409. 2015.PubMed/NCBI View Article : Google Scholar

18 

Saeed M, Gao J, Shi Y, Lammers T and Yu H: Engineering nanoparticles to reprogram the tumor immune microenvironment for improved cancer immunotherapy. Theranostics. 9:7981–8000. 2019.PubMed/NCBI View Article : Google Scholar

19 

van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM and Lammers T: Smart cancer nanomedicine. Nat Nanotechnol. 14:1007–1017. 2019.PubMed/NCBI View Article : Google Scholar

20 

Raza F, Zafar H, You X, Khan A, Wu J and Ge L: Cancer nanomedicine: Focus on recent developments and self-assembled peptide nanocarriers. J Mater Chem B Mater Biol Med. 7:7639–7655. 2019.PubMed/NCBI View Article : Google Scholar

21 

Thakur V and Kutty RV: Recent advances in nanotheranostics for triple negative breast cancer treatment. J Exp Clin Cancer Res. 38(430)2019.PubMed/NCBI View Article : Google Scholar

22 

Wang L, Huang J, Chen H, Wu H, Xu Y, Li Y, Yi H, Wang YA, Yang L and Mao H: Exerting enhanced permeability and retention effect driven delivery by ultrafine iron oxide nanoparticles with T1-T2 switchable magnetic resonance imaging contrast. ACS Nano. 11:4582–4592. 2017.PubMed/NCBI View Article : Google Scholar

23 

Gholami A, Mousavi SM, Hashemi SA, Ghasemi Y, Chiang WH and Parvin N: Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy. Drug Metab Rev. 52:205–224. 2020.PubMed/NCBI View Article : Google Scholar

24 

Sharma H, Mishra PK, Talegaonkar S and Vaidya B: Metal nanoparticles: A theranostic nanotool against cancer. Drug Discov Today. 20:1143–1151. 2015.PubMed/NCBI View Article : Google Scholar

25 

Tomsa AM, Alexa AL, Junie ML, Rachisan AL and Ciumarnean L: Oxidative stress as a potential target in acute kidney injury. PeerJ. 7(e8046)2019.PubMed/NCBI View Article : Google Scholar

26 

Zuberek M and Grzelak A: Nanoparticles-caused oxidative imbalance. Adv Exp Med Biol. 1048:85–98. 2018.PubMed/NCBI View Article : Google Scholar

27 

Ghosn M, Kourie HR and Tabchi S: Gastrointestinal cancers in the era of theranostics: Updates and future perspectives. World J Gastroenterol. 21:8473–8477. 2015.PubMed/NCBI View Article : Google Scholar

28 

Zeng Q and Baker I: Iron/iron oxide nanoparticle and use thereof. Patent WO2012036978A1. Filed September 9, 2011; issued March 22, 2012.

29 

Abd-Elgaliel WR and Tung CH: Protease degradable polypeptides and uses thereof. Patent WO2012075241A3. Filed December 1, 2011; issued June 7, 2012.

30 

El-Sayed MEH and Yuksel Durmaz Y: Polymeric nanoparticles for ultrasound imaging and therapy. Patent WO2013055791A1. Filed October 10, 2012; issued April 18, 2013.

31 

Xian W, McKeon F, Vincent M, Crum C and Ho KY: Methods and reagents for detection and treatment of esophageal metaplasia. Patent WO2012044992A2. Filed September 30, 2011; issued April 5, 2012.

32 

Iyer K, Evans C, Clemons T, Fitzgerald M, Dunlop S, Luzinov I and Zdyrko B: Multifunctional nanoparticles. Patent WO2012075533A1. Filed December 7, 2011; issued June 14, 2012.

33 

Zhao Y: Nanoparticles and nanoparticle compositions. Patent WO2011130114A1. Filed April 8, 2011; issued October 20, 2011.

34 

Bayford RH, Roitt IM, Rademacher TW, Demosthenous A and Iles RK: Detection of cancer. Patent WO2010052503A1. Filed November 6, 2009; issued May 14, 2010.

35 

Zhu X, Lu N, Zhou Y, Xuan S, Zhang J, Giampieri F, Zhang Y, Yang F, Yu R, Battino M, et al: Targeting pancreatic cancer cells with peptide-functionalized polymeric magnetic nanoparticles. Int J Mol Sci. 20(2988)2019.PubMed/NCBI View Article : Google Scholar

36 

Wei QY, He KM, Chen JL, Xu YM and Lau ATY: Phytofabrication of nanoparticles as novel drugs for anticancer applications. Molecules. 24(4246)2019.PubMed/NCBI View Article : Google Scholar

37 

Fang L, Fan H, Guo C, Cui L, Zhang P, Mu H, Xu H, Zhao F and Chen D: Novel mitochondrial targeting multifunctional surface charge-reversal polymeric nanoparticles for cancer treatment. J Biomed Nanotechnol. 15:2151–2163. 2019.PubMed/NCBI View Article : Google Scholar

38 

Cavalcante GC, Schaan AP, Cabral GF, Santana-da-Silva MN, Pinto P, Vidal AF and Ribeiro-Dos-Santos Â: A cell's fate: An Overview of the molecular biology and genetics of apoptosis. Int J Mol Sci. 20(4133)2019.PubMed/NCBI View Article : Google Scholar

39 

Xia M, Zhang Y, Jin K, Lu Z, Zeng Z and Xiong W: Communication between mitochondria and other organelles: A brand-new perspective on mitochondria in cancer. Cell Biosci. 9(27)2019.PubMed/NCBI View Article : Google Scholar

40 

Cho YL, Tan HWS, Saquib Q, Ren Y, Ahmad J, Wahab R, He W, Bay BH and Shen HM: Dual role of oxidative stress-JNK activation in autophagy and apoptosis induced by nickel oxide nanoparticles in human cancer cells. Free Radic Biol Med. 153:173–186. 2020.PubMed/NCBI View Article : Google Scholar

41 

Chattopadhyay S, Dash SK, Tripathy S, Das B, Kar Mahapatra S, Pramanik P and Roy S: Cobalt oxide nanoparticles induced oxidative stress linked to activation of TNF-α/caspase-8/p38-MAPK signaling in human leukemia cells. J Appl Toxicol. 35:603–613. 2015.PubMed/NCBI View Article : Google Scholar

42 

Dai DF, Chiao YA, Martin GM, Marcinek DJ, Basisty N, Quarles EK and Rabinovitch PS: Mitochondrial-targeted catalase: Extended longevity and the roles in various disease models. Prog Mol Biol Transl Sci. 146:203–241. 2017.PubMed/NCBI View Article : Google Scholar

43 

Li Y and Ju D: The role of autophagy in nanoparticles-induced toxicity and its related cellular and molecular mechanisms. Adv Exp Med Biol. 1048:71–84. 2018.PubMed/NCBI View Article : Google Scholar

44 

Cordani M and Somoza Á: Targeting autophagy using metallic nanoparticles: A promising strategy for cancer treatment. Cell Mol Life Sci. 76:1215–1242. 2019.PubMed/NCBI View Article : Google Scholar

45 

Wallace DC: Mitochondria and cancer. Nat Rev Cancer. 12:685–698. 2012.PubMed/NCBI View Article : Google Scholar

46 

Guo R, Peng H, Tian Y, Shen S and Yang W: Mitochondria-targeting magnetic composite nanoparticles for enhanced phototherapy of cancer. Small. 12:4541–4552. 2016.PubMed/NCBI View Article : Google Scholar

47 

Yin B, Li KHK, Ho LWC, Chan CKW and Choi CHJ: Toward understanding in vivo sequestration of nanoparticles at the molecular level. ACS Nano. 12:2088–2093. 2018.PubMed/NCBI View Article : Google Scholar

48 

Bader JE, Enos RT, Velázquez KT, Carson MS, Nagarkatti M, Nagarkatti PS, Chatzistamou I, Davis JM, Carson JA, Robinson CM, et al: Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer. Am J Physiol Gastrointest Liver Physiol. 314:G22–G31. 2018.PubMed/NCBI View Article : Google Scholar

49 

Kim YJ, Perumalsamy H, Castro-Aceituno V, Kim D, Markus J, Lee S, Kim S, Liu Y and Yang DC: Photoluminescent and self-assembled hyaluronic acid-zinc oxide-ginsenoside Rh2 nanoparticles and their potential Caspase-9 apoptotic mechanism towards cancer cell lines. Int J Nanomedicine. 14:8195–8208. 2019.PubMed/NCBI View Article : Google Scholar

50 

Wang H, Zhang F, Wen H, Shi W, Huang Q, Huang Y, Xie J, Li P, Chen J, Qin L, et al: Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis. J Nanobiotechnology. 18(8)2020.PubMed/NCBI View Article : Google Scholar

51 

Gong N, Ma X, Ye X, Zhou Q, Chen X, Tan X, Yao S, Huo S, Zhang T, Chen S, et al: Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment. Nat Nanotechnol. 14:379–387. 2019.PubMed/NCBI View Article : Google Scholar

52 

Sun H, Jiang C, Wu L, Bai X and Zhai S: Cytotoxicity-related bioeffects induced by nanoparticles: the role of surface chemistry. Front Bioeng Biotechnol. 7(414)2019.PubMed/NCBI View Article : Google Scholar

53 

Kurtz-Chalot A, Villiers C, Pourchez J, Boudard D, Martini M, Marche PN, Cottier M and Forest V: Impact of silica nanoparticle surface chemistry on protein corona formation and consequential interactions with biological cells. Mater Sci Eng C. 75:16–24. 2017.PubMed/NCBI View Article : Google Scholar

54 

Wang Z, Wang C, Liu S, He W, Wang L, Gan J, Huang Z, Wang Z, Wei H, Zhang J, et al: Specifically formed corona on silica nanoparticles enhances transforming growth factor β1 activity in triggering lung fibrosis. ACS Nano. 11:1659–1672. 2017.PubMed/NCBI View Article : Google Scholar

55 

Vasileiou PVS, Evangelou K, Vlasis K, Fildisis G, Panayiotidis MI, Chronopoulos E, Passias PG, Kouloukoussa M, Gorgoulis VG and Havaki S: Mitochondrial homeostasis and cellular senescence. Cells. 8(686)2019.PubMed/NCBI View Article : Google Scholar

56 

Burgos-Morón E, Abad-Jiménez Z, Marañón AM, Iannantuoni F, Escribano-López I, López-Domènech S, Salom C, Jover A, Mora V, Roldan I, et al: Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: The Battle Continues. J Clin Med. 8(1385)2019.PubMed/NCBI View Article : Google Scholar

57 

Balan C, Chis MI, Rachisan AL and Baia M: A vibrational study of inulin by means of experimental and theoretical methods. J Mol Struct. 1164:84–88. 2018.

58 

Picos A, Rachisan AL and Dadarlat A: Minimally invasive dental treatment using composites and ceramics in GERD diagnoses patients. Mater Plast. 55:252–254. 2018.

59 

Lin LS, Wang JF, Song J, Liu Y, Zhu G, Dai Y, Shen Z, Tian R, Song J, Wang Z, et al: Cooperation of endogenous and exogenous reactive oxygen species induced by zinc peroxide nanoparticles to enhance oxidative stress-based cancer therapy. Theranostics. 9:7200–7209. 2019.PubMed/NCBI View Article : Google Scholar

60 

Sur S, Nakanishi H, Flaveny C, Ippolito JE, McHowat J, Ford DA and Ray RB: Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract. Cell Commun Signal. 17(131)2019.PubMed/NCBI View Article : Google Scholar

61 

Huo D, Zhu J, Chen G, Chen Q, Zhang C, Luo X, Jiang W, Jiang X, Gu Z and Hu Y: Eradication of unresectable liver metastasis through induction of tumour specific energy depletion. Nat Commun. 10(3051)2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tomşa AM, Picoş A, Picoş AM and Răchişan AL: Mitochondrial nanotargeting in malignancies (Review). Exp Ther Med 20: 3444-3451, 2020.
APA
Tomşa, A.M., Picoş, A., Picoş, A.M., & Răchişan, A.L. (2020). Mitochondrial nanotargeting in malignancies (Review). Experimental and Therapeutic Medicine, 20, 3444-3451. https://doi.org/10.3892/etm.2020.9023
MLA
Tomşa, A. M., Picoş, A., Picoş, A. M., Răchişan, A. L."Mitochondrial nanotargeting in malignancies (Review)". Experimental and Therapeutic Medicine 20.4 (2020): 3444-3451.
Chicago
Tomşa, A. M., Picoş, A., Picoş, A. M., Răchişan, A. L."Mitochondrial nanotargeting in malignancies (Review)". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3444-3451. https://doi.org/10.3892/etm.2020.9023
Copy and paste a formatted citation
x
Spandidos Publications style
Tomşa AM, Picoş A, Picoş AM and Răchişan AL: Mitochondrial nanotargeting in malignancies (Review). Exp Ther Med 20: 3444-3451, 2020.
APA
Tomşa, A.M., Picoş, A., Picoş, A.M., & Răchişan, A.L. (2020). Mitochondrial nanotargeting in malignancies (Review). Experimental and Therapeutic Medicine, 20, 3444-3451. https://doi.org/10.3892/etm.2020.9023
MLA
Tomşa, A. M., Picoş, A., Picoş, A. M., Răchişan, A. L."Mitochondrial nanotargeting in malignancies (Review)". Experimental and Therapeutic Medicine 20.4 (2020): 3444-3451.
Chicago
Tomşa, A. M., Picoş, A., Picoş, A. M., Răchişan, A. L."Mitochondrial nanotargeting in malignancies (Review)". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3444-3451. https://doi.org/10.3892/etm.2020.9023
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team